Depression and chronic liver disease (CLD) are important causes of disability, morbidity and
mortality worldwide and their prevalence continues to rise. The rate of depression in CLD is …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the hepatic component of the
metabolic syndrome and now seemingly affects one-fourth of the world population. Features …

Emerging evidence demonstrates that alterations to the gut microbiota can affect mood,
suggesting that the microbiota–gut–brain (MGB) axis contributes to the pathogenesis of …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease characterized by multiple
pathologies. The progression of dementia with NAFLD may be affected by various risk …

Background and Aims: Both non-alcoholic fatty liver disease (NAFLD) and depression have
a high global prevalence which is projected to increase further. While studies exploring the …

Physical exercise is effective in alleviating mental disorders by improving synaptic
transmission; however, the link between body endurance training and neural adaptation has …

Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease
worldwide, and is frequently linked to the metabolic syndrome. The latter represents a …

Non-alcoholic steatohepatitis (NASH) is a progressive, inflammatory liver disease with no
approved pharmacological treatment. This Phase IIa, double-blind, placebo-controlled …

Background Nonalcoholic fatty liver disease (NAFLD) is associated with an increased
prevalence of psychological conditions such as depression and anxiety. However, the …

Conclusions: Most guidelines recommend weight reduction through physical activity and
improving nutrition, as these have proven positive effects on health outcomes when …